TMCnet - World's Largest Communications and Technology Community



Transgene Announces Upcoming Investor Meetings and R&D Day
[April 10, 2017]

Transgene Announces Upcoming Investor Meetings and R&D Day

Regulatory News:

Transgene (Paris:TNG) today announced that management will participate in the upcoming investor events set out below.

  • Kempen 10th Life Sciences Conference: April 19, 2017 - Amsterdam, Netherlands
  • Kepler Biotech Days: June 9, 2017 - Paris, France

Transgene will host a "R&D Day", on June 22, 2017 in Paris, France. The event which will be conducted in English will feature presentations from several leading international scientists and clinicians.

Next scheduled financial communication

1st quarter 2017 business update
April 25, 2017 after market close

About Transgene
Transgene S.A. (Euronext: TNG), part of Institut Mériux, is a publicly traded French biopharmaceutical company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene's programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells. The Company's two lead clinical-stage programs are: TG4010, a therapeutic vaccine for non-small cell lung cancer and Pexa-Vec, an oncolytic virus for liver cancer. The Company has several other programs in clinical and preclinical development. Transgene is based in Strasbourg, France, and has additional operations in Lyon, as well as a joint venture in China. Additional information about Transgene is available at

Follow us on Twitter (News - Alert): @TransgeneSA

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy